natgillin/translations-raw huggingface dataset:
EU/1/02/219/023 14 film-coated tablets EU/1/02/219/024 28 film-coated tablets EU/1/02/219/025 42 film-coated tablets EU/1/02/219/026 49 x 1 film-coated tablets EU/1/02/219/027 56 film-coated tablets EU/1/02/219/028 56 x 1 film-coated tablets EU/1/02/219/029 70 film-coated tablets EU/1/02/219/030 84 film-coated tablets EU/1/02/219/031 98 film-coated tablets EU/1/02/219/032 98 x 1 film-coated tablets EU/1/02/219/033 100 x 1 film-coated tablets EU/1/02/219/034 112 film-coated tablets EU/1/02/219/037 14 film-coated tablets EU/1/02/219/038 28 film-coated tablets EU/1/02/219/039 42 film-coated tablets EU/1/02/219/040 49 x 1 film-coated tablets EU/1/02/219/041 56 film-coated tablets EU/1/02/219/042 56 x 1 film-coated tablets EU/1/02/219/043 70 film-coated tablets EU/1/02/219/044 84 film-coated tablets EU/1/02/219/045 98 film-coated tablets EU/1/02/219/046 98 x 1 film-coated tablets EU/1/02/219/047 100 x 1 film-coated tablets EU/1/02/219/048 112 film-coated tablets
EU/1/02/219/023 14 filmsko obložene tablete EU/1/02/219/024 28 filmsko obložene tablete EU/1/02/219/025 42 filmsko obložene tablete EU/1/02/219/026 49 x 1 filmsko obložene tablete EU/1/02/219/027 56 filmsko obložene tablete EU/1/02/219/028 56 x 1 filmsko obložene tablete EU/1/02/219/029 70 filmsko obložene tablete EU/1/02/219/030 84 filmsko obložene tablete EU/1/02/219/031 98 filmsko obložene tablete EU/1/02/219/032 98 x 1 filmsko obložene tablete EU/1/02/219/033 100 x 1 filmsko obložene tablete EU/1/02/219/034 112 filmsko obložene tablete EU/1/02/219/037 14 filmsko obložene tablete EU/1/02/219/038 28 filmsko obložene tablete EU/1/02/219/039 42 filmsko obložene tablete EU/1/02/219/040 49 x 1 filmsko obložene tablete EU/1/02/219/041 56 filmsko obložene tablete EU/1/02/219/042 56 x 1 filmsko obložene tablete EU/1/02/219/043 70 filmsko obložene tablete EU/1/02/219/044 84 filmsko obložene tablete EU/1/02/219/045 98 filmsko obložene tablete EU/1/02/219/046 98 x 1 filmsko obložene tablete EU/1/02/219/047 100 x 1 filmsko obložene tablete EU/1/02/219/048 112 filmsko obložene tablete
The pack sizes 49 x 1, 56 x 1, 98 x 1 and 100 x 1 film-coated tablets are presented in unit dose blister.
V škatlicah z 49 x 1, 56 x 1, 98 x 1 in 100 x 1 filmsko obloženo tableto se tablete nahajajo v pretisnem omotu za enkratni odmerek.
Ebixa contains the active substance memantine hydrochloride.
Zdravilo Ebixa vsebuje zdravilno učinkovino memantinijev klorid.
Oral solution 50 ml
peroralna raztopina 50 ml
Tablet cores for 10/20 mg film-coated tablets: Microcrystalline cellulose Croscarmellose sodium Colloidal anhydrous silica Magnesium stearate
Jedro tablete pri 10/20 mg filmsko obloženih tabletah: mikrokristalna celuloza natrijev karmelozat, premreženi brezvoden koloidni silicijev dioksid magnezijev stearat
Do not use this medicine after the expiry date which is stated on the carton and the bottle label after EXP.
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in nalepki na steklenički poleg oznake EXP. Rok uporabnosti zdravila se izteče na zadnji dan navedenega meseca.
Ebixa 10 mg film-coated tablets: Pack sizes of 14, 28, 30, 42, 50, 56, 70, 84, 98, 100,112 film-coated tablets.
Ebixa 10 mg filmsko obložene tablete: Pakiranje s 14, 28, 30, 42, 50, 56, 70, 84, 98, 100, 112 filmsko obloženimi tabletami.
6.6 Special precautions for disposal and other handling
6.6 Posebni varnostni ukrepi za odstanjevanje in ravnanje z zdravilom
Ebixa 5 mg film-coated tablets Ebixa 10 mg film-coated tablets Ebixa 15 mg film-coated tablets Ebixa 20 mg film-coated tablets
Ebixa 5 mg filmsko obložene tablete Ebixa 10 mg filmsko obložene tablete Ebixa 15 mg filmsko obložene tablete Ebixa 20 mg filmsko obložene tablete
Ebixa film-coated tablets are available in blister packs of 14 tablets, 28 tablets, 42 tablets, 49 x 1 tablets, 56 tablets, 56 x 1 tablets, 70 tablets, 84 tablets, 98 tablets, 98 x 1 tablets, 100 x 1 tablets, 112 tablets or 840 (20 x 42) tablets.
Ebixa tablete se nahajajo v pretisnih omotih v škatlicah s 14 tabletami, 28 tabletami, 42 tabletami, 49 x 1 tableto, 56 tabletami, 56 x 1 tableto, 70 tabletami, 84 tabletami, 98 tabletami, 98 x 1 tableto, 100 x 1 tableto, 112 tabletami ali 840 tabletami (20 x 42).
Ebixa acts on these NMDA-receptors improving the transmission of nerve signals and the memory.
Ebixa spada v skupino zdravil, ki se imenujejo antagonisti receptorjev NMDA. Ebixa deluje na receptorje NMDA in izboljša prenos živčnih signalov in spomin.
Talk to your doctor or pharmacist before taking Ebixa:
Pred začetkom jemanja zdravila Ebixa se posvetujte z zdravnikom ali farmacevtom:
The usual starting dose is one pump actuation once daily (1x 5 mg) for the first week.
Običajni začetni odmerek je en pritisk navzdol enkrat dnevno (1 x 5 mg) v prvem tednu.
Ebixa should be administered orally once a day.
Zdravilo Ebixa jemljite peroralno enkrat dnevno.
Ebixa film-coated tablets are available in blister packs of 14 tablets, 28 tablets, 30 tablets, 42 tablets, 49 x 1 tablets, 50 tablets, 56 tablets, 56 x 1 tablets, 70 tablets, 84 tablets, 98 tablets, 98 x 1 tablets, 100 tablets, 100 x 1 tablets, 112 tablets, 980 (10 x 98) tablets or 1000 (20 x 50) tablets.
Ebixa tablete se nahajajo v pretisnih omotih v škatlicah s 14 tabletami, 28 tabletami, 30 tabletami, 42 tabletami, 49 x 1 tableto, 50 tabletami, 56 tabletami, 56 x 1 tableto, 70 tabletami, 84 tabletami, 98 tabletami, 98 x 1 tableto, 100 tabletami, 100 x 1 tableto, 112 tabletami, 980 tabletami (10 x 98) ali 1000 (20 x 50) tabletami.
CARTON FOR BLISTER PACK
ŠKATLA ZA PRETISNI OMOT
Additional for 20 mg film-coated tablets: Irion oxide yellow and red
Dodatno za 20 mg filmsko obložene tablete: železov oksid rumen in rdeč
Memantine hydrochloride Week 4, Day 22 23 24 25 26 27 28 7 Film-coated tablets Ebixa 20 mg
Ebixa 20 mg memantinijev klorid Teden 4, Dan 22 23 24 25 26 27 28 7 filmsko obloženih tablet Ebixa 20 mg
Memantine hydrochloride Week 3, Day 15 16 17 18 19 20 21 7 Film-coated tablets Ebixa 15 mg
Ebixa 15 mg memantinijev klorid Teden 3, Dan 15 16 17 18 19 20 21 7 filmsko obloženih tablet Ebixa 15 mg
Film-coated tablets 14 film-coated tablets 28 film-coated tablets 42 film-coated tablets 49 x 1 film-coated tablets 56 film-coated tablets 56 x 1 film-coated tablets 70 film-coated tablets 84 film-coated tablets 98 film-coated tablets 98 x 1 film-coated tablets 100 x 1 film-coated tablets 112 film-coated tablets
filmsko obložene tablete 14 filmsko obloženih tablet 28 filmsko obloženih tablet 42 filmsko obloženih tablet 49 x 1 filmsko obložena tableta 56 filmsko obloženih tablet 56 x 1 filmsko obložena tableta 70 filmsko obloženih tablet 84 filmsko obloženih tablet 98 filmsko obloženih tablet 98 x 1 filmsko obložena tableta 100 x 1 filmsko obložena tableta 112 filmsko obloženih tablet
From Week 4 on The patient should take 2 ml solution (20 mg) equivalent to four pump actuations once a day.
Od 4. tedna dalje Bolnik mora jemati 2 ml raztopine (20 mg) enkrat na dan, kar ustreza štirim pritiskom navzdol.
Lock the dosing pump after using Ebixa.
Po uporabi zdravila Ebixa zaklenite odmerno črpalko.
Week 2 (day 8-14): Take one 10 mg tablet once a day (pale yellow to yellow, oval shaped) for 7 days.
2. teden (8.-14. dan): Vzemite po eno 10 mg tableto enkrat dnevno (bledo rumena do rumena, ovalna), jemljite 7 dni.
- The other ingredients for Ebixa 5/10/15 and 20 mg film-coated tablets are microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate, all in the tablet core; and hypromellose, macrogol 400, titanium dioxide (E 171) and additional for Ebixa 10 mg film-coated tablets is iron oxide yellow (E172) and for Ebixa 15 mg and Ebixa 20 mg film-coated tablets are iron oxide yellow and red (E 172), all in the tablet coating.
- Druge sestavine zdravila so mikrokristalna celuloza, premrežen natrijev karmelozat, brezvoden koloidni silicijev dioksid, in magnezijev stearat, vse v jedru tablete; ter hipermeloza, makrogol 400, titanov dioksid (E 171) in dodatno pri zdravilu Ebixa 10 mg filmsko obležene tablete še rumeni železov oksid (E172) in pri zdravilu Ebixa 15 mg in Ebixa 20 mg filmsko oblože tablete rumeni in rdeči železov oksid (E 172), vse v oblogi tablete.
- The active substance is memantine hydrochloride.
- Zdravilna učinkovina je memantinijev klorid.
Week 3 (day 15-21): Take one 15 mg tablet once a day (grey-orange, oval-oblong) for 7 days.
3. teden (15.-21. dan): Vzemite po eno 15 mg tableto enkrat dnevno (sivo oranžna, ovalno podolgovata), jemljite 7 dni.
one and a half 10 mg tablets week 4 and beyond two 10 mg tablets once a day
4. teden in naprej dve 10 mg tableti enkrat dnevno
The bottle with the mounted pump may only be kept and transported in a vertical position.
Stekleničko z nameščeno črpalko lahko hranimo in prenašamo le v pokončnem položaju.
The recommended dose of Ebixa for adults and older people is four pump actuations, equivalent to 20 mg once a day.
Za odrasle in starejše bolnike je priporočeni odmerek zdravila Ebixa štiri polni pritiski navzdol, kar ustreza 20 mg enkrat dnevno.
Film-coated tablets 14 film-coated tablets 28 film-coated tablets 30 film-coated tablets 42 film-coated tablets 49 x 1 film-coated tablets 50 film-coated tablets 56 film-coated tablets 56 x 1 film-coated tablets 70 film-coated tablets 84 film-coated tablets 98 film-coated tablets 98 x 1 film-coated tablets 100 film-coated tablets 100 x 1 film-coated tablets 112 film-coated tablets
filmsko obložene tablete 14 filmsko obloženih tablet 28 filmsko obloženih tablet 30 filmsko obloženih tablet 42 filmsko obloženih tablet 49 x 1 filmsko obloženih tablet 50 filmsko obloženih tablet 56 filmsko obloženih tablet 56 x 1 filmsko obloženih tablet 70 filmsko obloženih tablet 84 filmsko obloženih tablet 98 filmsko obloženih tablet 98 x 1 filmsko obloženih tablet 100 filmsko obloženih tablet 100 x 1 filmsko obloženih tablet 112 filmsko obloženih tablet
FREQUENCY ADVERSE REACTION
Neznane pogostnosti psihotične reakcije
Think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Če ste noseči ali dojite, menite, da bi lahko bili noseči ali načrtujete zanositev, s posvetujte z zdravnikom ali farmacevtom, preden vzamete to zdravilo.
- The other ingredients are microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate, all in the tablet core; and hypromellose, macrogol 400, titanium dioxide (E 171), iron oxide yellow and red (E 172), all in the tablet coating.
- Druge sestavine zdravila so mikrokristalna celuloza, premrežen natrijev karmelozat, brezvoden koloidni silicijev dioksid, in magnezijev stearat, vse v jedru tablete; ter hipermeloza, makrogol 400, titanov dioksid (E 171) rumeni in rdeči železov oksid (E 172), vse v oblogi tablete.
Memantine hydrochloride Week 2, Day 8 9 10 11 12 13 14 7 Film-coated tablets Ebixa 10 mg
Ebixa 10 mg memantinijev klorid Teden 2, Dan 8 9 10 11 12 13 14 7 filmsko obloženih tablet Ebixa 10 mg
One pump actuation contains 5 mg memantine hydrochloride.
En pritisk navzdol vsebuje 5 mg memantinijevega klorida.
Week 1 (day 1-7): Take one 5 mg tablet once a day (white to off-white, oval-oblong) for 7 days.
1. teden (1.-7. dan): Vzemite po eno 5 mg tableto enkrat dnevno (bela do belkasta, ovalno podolgovata), jemljite 7 dni.
Do not use this medicine after the expiry date which is stated on the carton and the blister after EXP.
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in na pretisnem omotu poleg oznake EXP. Rok uporabnosti se izteče na zadnji dan navedenega meseca.
Week 2 (day 8-14) The patient should take one 10 mg film-coated tablet (10 mg) per day for 7 days.
2. teden (8.-14. dan) Bolnik mora sedem dni jemati eno 10 mg filmsko obloženo tableto (10 mg) na dan.
MINIMUM PARTICULARS TO APPEAR ON BLISTER
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA PRETISNEM OMOTU
In patients with severe renal impairment (creatinine clearance 5 - 29 ml/min) daily dose should be 10 mg per day.
Pri bolnikih s hudo okvaro delovanja ledvic (očistek kreatinina 5 - 29 ml/min) naj bo dnevni odmerek 10 mg na dan.
What Ebixa contains
Kaj vsebuje zdravilo Ebixa
Week 2 (day 8-14) The patient should take 1 ml solution (10 mg) equivalent to two pump actuations per day for 7 days.
2. teden (8.-14. dan) Bolnik mora sedem dni jemati 1 ml raztopine (10 mg) na dan, kar ustreza dvema pritiskoma navzdol.
Week 1 (day 1-7) The patient should take half a 10 mg film-coated tablet (5 mg) per day for 7 days.
1. teden (1.-7. dan) Bolnik mora sedem dni jemati polovico 10 mg filmsko obložene tablete (5 mg) na dan.
The recommended dose of Ebixa for adults and older people is 20 mg once a day.
Za odrasle in starejše bolnike je priporočeni odmerek zdravila Ebixa 20 mg enkrat dnevno.
OUTER WRAPPER LABEL ON MULTIPACKS WRAPPED IN FOIL (INCLUDING BLUE BOX)
ZUNANJA NALEPKA NA VEČKRATNEM PAKIRANJU V FOLIJI (VKLJUČUJOČ t.i.
- The other ingredients are microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica and magnesium stearate, all in the tablet core; and hypromellose, macrogol 400, titanium dioxide (E171) and iron oxide yellow (E172), all in the tablet coating.
- Druge sestavine zdravila so mikrokristalna celuloza, premrežen natrijev karmelozat, brezvoden koloidni silicijev dioksid in magnezijev stearat, vse v jedru tablete; ter hipermeloza, makrogol 400, titanov dioksid (E 171) in rumeni železov oksid (E 172), vse v oblogi tablete.
Ebixa 10 mg film-coated tablets Ebixa 20 mg film-coated tablets
Ebixa 10 mg filmsko obložene tablete Ebixa 20 mg filmsko obložene tablete
Week 3 (day 15-21) The patient should take 1.5 ml solution (15 mg) equivalent to three pump actuations per day for 7 days.
3. teden (15.-21. dan) Bolnik mora sedem dni jemati 1.5 ml raztopine (15 mg) na dan, kar ustreza trem pritiskom navzdol.
Week 3 (day 15-21): The patient should take one and a half 10 mg film-coated tablets (15 mg) per day for 7 days.
3. teden (15.-21. dan) Bolnik mora sedem dni jemati eno in pol 10 mg filmsko obloženo tableto (15 mg) na dan.
Week 4 (day 22-28) The patient should take one 20 mg film-coated tablet per day (grey-red, oval-oblong) for 7 days.
4. teden (22.-28. dan) Bolnik naj 7 dni jemlje eno 20 mg filmsko obloženo tableto na dan (sivo rdeča, ovalno podolgovata).
The solution is clear and colourless to light yellowish.
peroralna raztopina Raztopina je prozorna in brezbarvna do rahlo rumenkasta.
three pump actuations week 4 and beyond
4. teden in naprej štirje pritiski navzdol
In patients with severe renal impairment (creatinine clearance 529 ml/min) daily dose should be 10 mg (1 ml solution, equivalent to two pump actuations) per day.
Pri bolnikih s hudo okvaro delovanja ledvic (očistek kreatinina 5 - 29 ml/min) naj bo dnevni odmerek 10 mg (1 ml raztopine, kar ustreza dvema pritiskoma navzdol).
Week 1 (day 1-7) The patient should take 0.5 ml solution (5 mg) equivalent to one pump actuation per day for 7 days.
1. teden (1.-7. dan) Bolnik mora sedem dni jemati 0.5 ml raztopine (5 mg) na dan, kar ustreza enemu pritisku navzdol.
Ebixa 10 mg film-coated tablets
Ebixa 10 mg filmsko obložene tablete
7 film-coated tablets of Ebixa 20 mg
7 filmsko obloženih tablet Ebixa 20 mg
Ebixa 20 mg film-coated tablets Memantine hydrochloride
Ebixa 20 mg filmsko obložene tablete memantinijev klorid
In patients with moderate renal impairment (creatinine clearance 3049 ml/min) daily dose should be 10 mg per day.
Pri bolnikih z zmerno okvaro delovanja ledvic (očistek kreatinina 30 - 49 ml/min) naj bo dnevni odmerek 10 mg.
Additional for 10 mg film-coated tablets: Iron oxide yellow
Dodatno za 10 mg filmsko obložene tablete: železov oksid, rumen
Tablet cores for 5/10/15/20 mg film-coated tablets: Microcrystalline cellulose Croscarmellose sodium
Jedro tablete pri 5/10/15/20 mg filmsko obloženih tabletah: mikrokristalna celuloza natrijev karmelozat, premreženi brezvoden koloidni silicijev dioksid magnezijev stearat
BLISTER FOR TABLETS
PRETISNI OMOT ZA TABLETE
Ebixa 10 mg film-coated tablets Memantine hydrochloride
Ebixa 10 mg filmsko obložene tablete memantinijev klorid
Week 4 (day 22-28): Take one 20 mg tablet per day (grey-red, oval-oblong) for 7 days.
4. teden (22.-28. dan): Vzemite po eno 20 mg tableto enkrat dnevno (sivo rdeča, ovalno podolgovata), jemljite 7 dni.
Treatment initiation pack
Pakiranje za uvajalno zdravljenje.
Gait abnormal
Občasni neobičajna hoja
Potassium sorbate Sorbitol E420
6.1 Seznam pomožnih snovi kalijev sorbat sorbitol E420 prečiščena voda
7 film-coated tablets of Ebixa 15 mg
7 filmsko obloženih tablet Ebixa 15 mg
Each pump actuation delivers 0.5 ml of solution which contains 5 mg of memantine hydrochloride which is equivalent to 4.16 mg memantine.
Vsaka aktivacija črpalke (en pritisk navzdol) dovede 0.5 ml raztopine, ki vsebuje 5 mg memantinijevega klorida, kar ustreza 4.16 mg memantina.
Ebixa 5 mg/pump actuation oral solution Memantine hydrochloride
Ebixa 5 mg/pritisk peroralna raztopina memantinijev klorid
7 film-coated tablets of Ebixa 10 mg
7 filmsko obloženih tablet Ebixa 10 mg
Ebixa 20 mg film-coated tablets
Ebixa 20 mg filmsko obložene tablete
• Headache, sleepiness, constipation, elevated liver function tests, dizziness, balance disorders,
• glavobol, zaspanost, zaprtje, zvišane vrednosti testov jetrne funkcije, omotica, motnje ravnotežja, zasoplost, visok krvni tlak in preobčutljivost za zdravilo
Ebixa 5 mg/pump actuation oral solution
Ebixa 5 mg/pritisk peroralna raztopina
Hallucinations
Občasni halucinacije
If you get any side effects, talk to your doctor or pharmacis.
Če opazite kateri koli neželeni učinek, se posvetujte z zdravnikom ali farmacevtom.
EXP {MM.YYYY} See embossed stamp.
Uporabno do: {MM.LLLL} Glejte reljefni odtis.
two pump actuations week 3
2. teden dva pritiska navzdol
The 15 mg film-coated tablets are orange to grey-orange, oval-oblong film-coated tablets with imprint ‘15' on one side and imprint ‘MEM' on the other side.
15 mg filmsko obložene tablete so oranžne do sivo oranžne, ovalno podolgovate, z vtisnjeno številko "15" na eni strani in vtisnjeno besedo "MEM" na drugi strani.
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
PODATKI NA PRETISNIH OMOTIH ALI TRAKOVIH
Ebixa 15 mg film-coated tablets are presented as orange to grey-orange, oval-oblong with imprint ‘15' on one side and imprint ‘MEM' on the other side.
Ebixa 15 mg filmsko obložene tablete so oranžne do sivo oranžne, ovalno podolgovate, z vtisnjeno številko "15" na eni strani in vtisnjeno besedo "MEM" na drugi strani.
How to store Ebixa
Shranjevanje zdravila Ebixa
Before you take Ebixa
Ne jemljite zdravila Ebixa
Week 1 (day 1-7) The patient should take one 5 mg film-coated tablet per day (white to off-white, oval-oblong) for 7 days.
Bolnik naj 7 dni jemlje eno 5 mg filmsko obloženo tableto na dan (bela do belkasta, ovalno podolgovata).
Ebixa 5 mg film-coated tablets are presented as white to off-white, oval-oblong with imprint ‘5' on one side and imprint ‘MEM' on the other side.
Ebixa 5 mg filmsko obložene tablete so bele do belkaste, ovalno podolgovate, z vtisnjeno številko "5" na eni strani in vtisnjeno besedo "MEM" na drugi strani.
Ebixa 10 mg film-coated tablets are presented as pale yellow to yellow, oval shaped film-coated tablet with breaking line and engravings ‘1 0' on one side and ‘M M' on the other side.
Ebixa 10 mg filmsko obložene tablete so bledo rumene do rumene, ovalne, z razdelilno zarezo in vtisnjeno številko "1 0" na eni strani in vtisnjeno besedo "M M" na drugi strani.
Tablet coat for 5/10/15/20 mg film-coated tablets: Hypromellose
Obloga tablete pri 5/10/15/20 mg filmsko obloženih tabletah: hipermeloza makrogol 400 titanov dioksid
The 20 mg film-coated tablets are pale red to grey-red, oval-oblong film-coated tablets with imprint ‘20' on one side and imprint ‘MEM' on the other side.
20 mg filmsko obložene tablete so bledo rdeče do sivo rdeče, ovalno podolgovate, z vtisnjeno številko "20" na eni strani in vtisnjeno besedo "MEM" na drugi strani.
Ebixa 5 mg
Ebixa 5 mg/pritisk raztopina
Ebixa 20 mg film-coated tablets are presented as are pale red to grey-red, oval-oblong with imprint ‘20' on one side and imprint ‘MEM' on the other side.
Ebixa 20 mg filmsko obložene tablete so bledo rdeče do sivo rdeče, ovalno podolgovate, z vtisnjeno številko "20" na eni strani in vtisnjeno besedo "MEM" na drugi strani.
Ebixa film-coated tablets are presented as pale yellow to yellow, oval shaped film-coated tablet with breaking line and engravings “1 0” on one side and “M M” on the other side.
Ebixa filmsko obložene tablete so bledo rumene do rumene, ovalne, filmsko obložene tablete z razdelilno zarezo in vtisnjeno številko "1 0" na eni strani in besedo "M M" na drugi strani.
Dose titration
Občasni bruhanje
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR INTERMEDIATE PACK / COMPONENT OF A MULTIPACK (WITHOUT BLUE BOX)
ŠKATLA ZA PRIMARNO OVOJNINO/DEL VEČKRATNEGA PAKIRANJA (BREZ t.i. MODREGA OKENCA)
Lot {number} See embossed stamp.
Številka serije {številka} Glejte reljefni odtis.
Ebixa film-coated tablets are presented as pale red to grey-red, oval-oblong film-coated tablets with imprint ‘20' on one side and imprint ‘MEM' on the other side.
Ebixa filmsko obložene tablete so bledo rdeče do sivo rdeče, ovalno podolgovate, filmsko obložene tablete z vtisnjeno številko "20" na eni strani in besedo "MEM" na drugi strani.
The 5 mg film-coated tablets are white to off-white, oval-oblong film-coated tablets with imprint ‘5' on one side and imprint ‘MEM' on the other side.
5 mg filmsko obložene tablete so bele do belkaste, ovalno podolgovate, z vtisnjeno številko "5" na eni strani in vtisnjeno besedo "MEM" na drugi strani.
Pale red to grey-red, oval-oblong film-coated tablets with imprint “20” on one side and “MEM” on the other side
Bledo rdeče do sivo rdeče, ovalno podolgovate filmsko obložene tablete, z vtisnjeno številko "20" na eni strani in vtisnjeno besedo "MEM" na drugi strani.
one pump actuation week 2
1. teden en pritisk navzdol
The 10 mg film-coated tablets are pale yellow to yellow, oval shaped film-coated tablet with breaking line and imprint ‘1 0' on one side and ‘M M' on the other side.
10 mg filmsko obložene tablete so bledo rumene do rumene, ovalne, z razdelilno zarezo in vtisnjeno številko "1 0" na eni strani in vtisnjeno besedo "M M" na drugi strani.
Pale yellow to yellow, oval shaped film-coated tablets with breaking line and imprint “1 0” on one side and “M M” on the other side.
Bledo rumene do rumene, ovalne filmsko obložene tablete, z razdelilno zarezo in vtisnjeno številko "1 0" na eni strani in vtisnjeno besedo "M M" na drugi strani.
half a 10 mg tablet week 2
3. teden ena in pol 10 mg tableta
Elevated liver function test
Bolezni jeter, žolčnika in žolčevodov Pogosti zvišane vrednosti testov jetrne funkcije
Week 3 (day 15-21) The patient should take one 15 mg film-coated tablet per day (grey-orange, oval-oblong) for 7 days.
Bolnik naj 7 dni jemlje eno 15 mg filmsko obloženo tableto na dan (sivo oranžna, ovalno podolgovata).
The study showed beneficial effects of memantine treatment in comparison to placebo at 6 months (observed cases analysis for the clinician's interview based impression of change (CIBIC-plus): p=0.025; Alzheimer's disease cooperative study - activities of daily living (ADCS-ADLsev): p=0.003; severe impairment battery (SIB): p=0.002).
V klinični študiji, ki podpira vlogo za pridobitev dovoljenja za promet, pri skupini 252 bolnikov z zmerno do hudo Alzheimerjevo boleznijo (3-14 točk na lestvici KPSS ("Kratkem preskusu spoznavnih sposobnosti" oz. MMSE ali "Mini-mental State Examination") ob vključitvi je zdravljenje z memantinom v monoterapiji pokazalo izboljšanje v primerjavi s placebom, v obdobju 6 mesečnega zdravljenja (analiza opazovanih bolnikov, lestvice CIBIC-plus - ("Clinician's Interview-Based Impression of Change Plus Caregiver Input" oz. "Vtis sprememb na osnovi kliničnega intervjuja"): p=0,025; ADCS-ADLsev ("Alzheimer's Disease Consortium Studies Activities of Daily Livingmodified for severe dementia" oz. "Vprašalnik vsakodnevnih aktivnosti): p=0,003; SIB ("Severe Impairment Battery" oz. "Baterije za hudo prizadetost"): p=0,002).